From idea to ETF portfolio in minutes. Build yours now →
XBIvsIBBETF Comparison
SPDR S&P Biotech ETF (XBI) and iShares Biotechnology ETF (IBB) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XBI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.44% for IBB. XBI is down -2.01% year-to-date (YTD) with -$310M in YTD flows. IBB performs worse with -4.14% YTD performance, and -$271M in YTD flows. Run a side-by-side ETF comparison of XBI and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
XBI vs IBB performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XBI IBB | -7.45%-7.64% | -5.37%-6.55% | -2.01%-4.14% | +34.99%+19.72% | +61.92%+29.54% | -8.42%+11.36% |
| Flows | XBI IBB | -$49M-$176M | -$569M-$390M | -$310M-$271M | -$86M+$482M | -$2.17B-$1.75B | +$1.02B-$2.38B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XBI IBB | +26.41%+20.85% | +28.20%+23.64% | +27.28%+19.48% | +32.68%+21.97% |
| Max drawdown | XBI IBB | -9.13%-8.90% | -21.44%-17.26% | -32.94%-24.82% | -55.10%-39.75% |
| Max drawdown duration | XBI IBB | 61d61d | 141d120d | 331d377d | 1791d1611d |
XBI | IBB | |
Last sale 3/24/2026 at 1:30 PM | $119.54 | $161.64 |
| Previous close 03/24/2026 | $121.70 | $162.69 |
| Consolidated volume 03/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XBI | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XBI | IBB | |
|---|---|---|
| Last price | $119.54 | $161.64 |
| 1D performance | -1.77% | -0.65% |
| AuM | $7.41 B | $7.73 B |
| E/R | 0.35% | 0.44% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the XBI and IBB ETFs performed in 2026?
As of March 24, 2026, XBI is down -2.01% year-to-date (YTD), while IBB has lost -4.14%. That puts XBI better performer ahead so far this year.
Which ETF is attracting more investor money: XBI or IBB?
Year-to-date, the XBI ETF saw -$310M in flows, compared to -$271M for IBB.
Which ETF is more volatile: XBI or IBB?
Over the past year, XBI had a volatility of 28.2%, while IBB experienced 23.64%.
Which ETF is bigger: XBI or IBB?
As of March 24, 2026, XBI holds $7.41 B in assets under management (AUM), while IBB manages $7.73 B.
What sectors do the XBI and IBB ETFs invest in?
XBI leans toward sectors like Health Care. Meanwhile, IBB focuses on Health Care.
What are the top holdings of the XBI ETF and IBB ETF?
XBI top holdings include MODERNA INC, ROIVANT SCIENCES LTD and VAXCYTE. IBB holds in its top three: GILEAD SCIENCES, VERTEX PHARMACEUTICALS and AMGEN-T.
Which ETF is more diversified: XBI or IBB?
XBI holds 147 securities with 22.98% of its assets in the top 15. IBB has 253 securities and a top 15 weight of 57.44%.
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
Are Biotechnology ETFs In the Midst of a Comeback?
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
Health is Wealth: A look at the Healthcare Sector
Two biotech ETFs to watch for the rest of 2022 and beyond
Two biotech ETFs to watch for the rest of 2022 and beyond
Biotech ETFs – Investing in Health Innovation
Build and Analyze Your ETF Portfolio Like a Pro
Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.
